Loading…
Loading…
EQUITY / NASDAQ · XNCM
Conexeu Sciences Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗3.57 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 3.57 USD · Volume 194,924
62 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
05/01/2026 – 07/31/2026 · Units
| Metric | 2026 / Quarter 3 | Prior year | Change |
|---|---|---|---|
| Cash and cash equivalents | 1,971,408 USD | — | — |
| Net income | -7,725,651 USD | — | — |
| Operating profit | -7,688,373 USD | — | — |
| Total assets | 7,156,074 USD | — | — |
| Total equity | 5,850,390 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 1,971,408 USD | — | — | 6,848,064 USD | — | — | 4,808,965 USD | — |
| Net incomeIncome statement | -7,725,651 USD | -11,748,757 USD | — | -2,304,283 USD | -4,023,106 USD | — | — | -1,298,570 USD |
| Operating profitIncome statement | -7,688,373 USD | -11,791,700 USD | — | -2,380,368 USD | -4,103,327 USD | — | — | -1,297,621 USD |
| Total assetsBalance sheet | 7,156,074 USD | — | — | 8,199,679 USD | — | — | 7,688,711 USD | — |
| Total equityBalance sheet | 5,850,390 USD | — | 7,196,383 USD | 7,196,383 USD | — | 6,826,402 USD | 7,352,693 USD | 1,654,900 USD |
| Total liabilitiesBalance sheet | 1,305,684 USD | — | — | 1,003,296 USD | — | — | 336,018 USD | — |
| Capital expendituresCash flow statement | — | 76,229 USD | — | — | 34,829 USD | — | — | — |
| Financing cash flowCash flow statement | — | 7,548,009 USD | — | — | 5,843,030 USD | — | — | — |
| Investing cash flowCash flow statement | — | -76,231 USD | — | — | -34,831 USD | — | — | — |
| Operating cash flowCash flow statement | — | -10,099,279 USD | — | — | -3,340,281 USD | — | — | — |
| Report source | Open report ↗ Published: 09/14/2026 | Open report ↗ Published: 09/14/2026 | Open report ↗ Published: 09/14/2026 | Open report ↗ Published: 06/15/2026 | Open report ↗ Published: 06/15/2026 | Open report ↗ Published: 06/15/2026 | Open report ↗ Published: 09/14/2026 | Open report ↗ Published: 09/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.